Intermediate-stage hepatocellular carcinoma patients with a high HBV-DNA load may benefit from postoperative anti-hepatitis B virus therapy.
| Autor: | Shaozhen Rui, Jun Yan, Hui Zhang, Zhengfeng Wang, Wence Zhou, Rui, Shaozhen, Yan, Jun, Zhang, Hui, Wang, Zhengfeng, Zhou, Wence |
|---|---|
| Zdroj: | Medicine; Jul2017, Vol. 96 Issue 30, p1-5, 5p, 2 Charts, 2 Graphs |
| Databáze: | Complementary Index |
| Externí odkaz: |
|